Cromer System

  • Helmut Schenkel-Brunner


Seven high-frequency and three low-frequency antigens of the Cromer system have been described (Table 21.1). Dimorphic variations are represented by Tca and Tc c in Europids, Tc a and Tc b in Negrids, and WES a and WES b in Negrids and Finns.


Blood Group Paroxysmal Nocturnal Haemoglobinuria Blood Group Antigen Complement Regulatory Protein Cryptic Splice Site 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Asch, A. S., Kinoshita, T., Jaffe, E. A. & Nussenzweiq, V. (1986): Decay-accelerating factor is present on cultured human umbilical vein endothelial cells. J. Exp. Med. 163, 221–226.PubMedCrossRefGoogle Scholar
  2. 2.
    Bergelson, J. M., Chan, M., Solomon, K. R., John, N. F. S., Lin, H. & Finberg, R. W. (1994): Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91, 6245–6248.PubMedCrossRefGoogle Scholar
  3. 3.
    Bergelson, J. M., Mohanty, J. G., Crowell, R. L., John, N. F. S., Lublin, D. M. & Finberg, R. W. (1995): Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69, 1903–1906.PubMedGoogle Scholar
  4. 4.
    Brodbeck, W. G., Liu, D. C., Sperry, J., Mold, C. & Medof, M. E. (1996): Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. J. Immunol. 156, 2528–2533.PubMedGoogle Scholar
  5. 5.
    Caras, I. W., Davitz, M. A., Rhee, G., Weddeul, G. N., Martin, D. W. & Nussenzweig, V. (1987): Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325, 545–549.PubMedCrossRefGoogle Scholar
  6. 6.
    Coyne, K. E., Hall, S. E., Thompson, E. S., Arce, m. A., Kinoshita, T., Fujita, T., Anstee, D. J., Rosse, W. & Lublin, D. M. (1992): Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149, 2906–2913.PubMedGoogle Scholar
  7. 7.
    Daniels, G. (1989): Cromer-related antigens — blood group determinants on decay-accelerating factor. Vox Sang. 56, 205–211.PubMedCrossRefGoogle Scholar
  8. 8.
    Daniels, G. & Walthers, L. (1986): Anti-IFC, an antibody made by Inab phenotype individuals. Transfusion 26, 117–118.PubMedCrossRefGoogle Scholar
  9. 9.
    Daniels, G. L., Green, C. A., Darr, F. W., Anderson, H. & Sistonen, P. (1987): A ‘new’ Cromer-related high frequency antigen probably antithetical to WES. Vox Sang. 53, 235–238.PubMedCrossRefGoogle Scholar
  10. 10.
    Daniels, G. L., Tohyama, H. & Uchikawa, M. (1982): A possible null phenotype in the Cramer blood group complex. Transfusion 22, 362–363.PubMedCrossRefGoogle Scholar
  11. 11.
    Karnauchow, T. M., Tolson, D. L., Harrison, B. A., Altman, E., Lublin, D. M. & Dimock, K. (1996): The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70, 5143–5152.PubMedGoogle Scholar
  12. 12.
    Kinoshita, T., Medof, M. E., Silber, R. & Nussenzweig, V. (1985): Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J. Exp. Med. 162, 75–92.PubMedCrossRefGoogle Scholar
  13. 13.
    Kuttner-Kondo, L., Medof, M. E., Brodbeck, W. & Shoham, M. (1996): Molecular modeling and mechanism of action of human decay-accelerating factor. Protein Eng. 9, 1143–1149.PubMedCrossRefGoogle Scholar
  14. 14.
    Lacey, P. A., Block, U. T., Laird-Fryer, B. J., Moulds, J. J., Bryant, L R., Giandelone, J. A. & Linnemeyer, D. R. (1985): Anti-Tcb, an antibody that defines a red cell antigen antithetical to Tca. Transfusion 25, 373–376.PubMedCrossRefGoogle Scholar
  15. 15.
    Laird-Fryer, B., Dukes, C. V., Lawson, J., Moulds, J. J., Walker, E. M. & Glassman, A. B. (1983): Tca: a high frequency blood group antigen. Transfusion 23, 124–127.PubMedCrossRefGoogle Scholar
  16. 16.
    Law, J., Judge, A., Covert, P., Lewis, N., Sabo, B. & Mccreary, J. (1982): A new low frequency factor proposed to be the product of an allele to Tca. (Abstract). Transfusion 22, 413.Google Scholar
  17. 17.
    Levene, C., Harel, N., Kende, G., Papo, S., Bradford, M. F. & Daniels, G. L. (1987): A second Dr(a-) proposita with anti-Dr” and a family with Dr(a-) in 2 generations. Transfusion 27, 64–65.PubMedCrossRefGoogle Scholar
  18. 18.
    Levene, C., Harel, N., Lavie, G., Greenberg, S., Laird-Fryer, B. & Daniels, G. L. (1984): A ‘new’ phenotype confirming a relationship between Cra and Tca. Transfusion 24, 13–15.PubMedCrossRefGoogle Scholar
  19. 19.
    Lewis, M., Anstee, D. J., Brid, G. W. G., Brodheim, E., Cartron, J. P., Contreras, M., Crookston, M. C., Dahr, W., Daniels, G. L., Engelfriet, C. P., Giles, C. M., Issitt, P. D., J0Rgensen, J., Kornstad, L., Lubenko, A., Marsh, W. L., Mccreary, J., Moore, B. P. L., Morel, P., Moulds, J. J., Nevanunna, H., Nordhagen, R., Okubo, Y., Rosenfield, R. E., Rouger, P., Rubinstein, P., Salmon, C., Seidl, S., Sistonen, P., Tippett, P., Walker, R. H., Woodfield, G. & Young, S. (1990): Blood group terminology 1990. Vox Sang. 58, 152–169.CrossRefGoogle Scholar
  20. 20.
    Lin, R. C., Herman, J., Henry, L. & Daniels, G. L. (1988): A family showing inheritance of the Inab phenotype. Transfusion 28, 427–429.PubMedCrossRefGoogle Scholar
  21. 21.
    Lublin, D. M. & Atkinson, J. P. (1989): Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7, 35–58.PubMedCrossRefGoogle Scholar
  22. 22.
    Lublin, D. M., Krsek-Staples, J., Pangburn, M. K. & Atkinson, J. P. (1986): Biosynthesis and glycosylation of the human complement regulatory protein decay accelerating factor. J. Immunol. 137, 1629–1635.PubMedGoogle Scholar
  23. 23.
    Lublin, D. M., Lemons, R. S., Le Beau, M. M., Holers, V. M., Tykocinski, M. L., Medof, M. E. & Atkinson, J. P. (1987): The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J. Exp. Med. 165, 1731–1736.PubMedCrossRefGoogle Scholar
  24. 24.
    Lublin, D. M., Mallinson, G., Poole, J., Reid, M. E., Thompson, E. S., Ferdman, B. R., Telen, M. J., Anstee, D. J. & Tanner, M. J. A. (1994): Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 84, 1276–1282.PubMedGoogle Scholar
  25. 25.
    Lublin, D. M., Thompson, E. S., Green, A. M., Levene, C. & Telen, M. J. (1991): Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants. J. Clin. Invest. 87, 1945–1952.PubMedCrossRefGoogle Scholar
  26. 26.
    Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P. & Tykocinski, M. L. (1987): Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84, 2007–2011.PubMedCrossRefGoogle Scholar
  27. 27.
    Medof, M. E., Walter, E. I., Rutgers, J. L., Knowles, D. M. & Nussenzweig, V. (1987): Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med. 165, 848–864.PubMedCrossRefGoogle Scholar
  28. 28.
    Nicholson-Weller, A., Bürge, J., Fearon, D. T., Weller, D. T. & Austen, K. F. (1982): Isolation of human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J. Immunol. 129, 184–189.PubMedGoogle Scholar
  29. 29.
    Nicholson-Weller, A., March, J. P., Rosen, C. E., Spicer, D. B. & Austen, K. F. (1985): Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system. Blood 69, 1237–1244.Google Scholar
  30. 30.
    Nowicki, B., Moulds, J., Hull, R. & Hull, S. (1988): A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen. Infect. Immun. 56, 1057–1060.PubMedGoogle Scholar
  31. 31.
    Petty, A. C., Daniels, G. L., Anstee, D. J. & Tippett, P. (1993): Use of the MAIEA technique to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang. 65, 309–315.PubMedCrossRefGoogle Scholar
  32. 32.
    Post, T. W., Arce, M. A., Liszewski, M. K., Thompson, E. S., Atkinson, J. P. & Lublin, D. M. (1990): Structure of the gene for human complement protein decay acceleration factor. J. Immunol. 144, 740–744.PubMedGoogle Scholar
  33. 33.
    Reid, M. E., Mallinson, G., Sim, R. B., Poole, J., Pausch, V., Merry, A. H., Liew, Y. W. & Tanner, M. J. A. (1991): Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency). Blood 78, 3291–3297.PubMedGoogle Scholar
  34. 34.
    Rey-Campos, J., Rubinstein, P. & Rodriguez De Cordoba, S. (1987): Decay accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans. J. Exp. Med. 166, 246–252.PubMedCrossRefGoogle Scholar
  35. 35.
    Slstonen, P., Nevanlinna, H. R., Virtaranta-Knowles, K., Tuominen, I., Plrkola, A., Green, C. A. & Tippett, P. (1987): WES, a ‘new’ infrequent blood group antigen in Finns. Vox Sang. 52, 111–114.CrossRefGoogle Scholar
  36. 36.
    Spring, F. A., Judson, P. A., Daniels, G. L., Parsons, S. F., Mallinson, G. & Anstee, D. J. (1987): A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 62, 307–313.PubMedGoogle Scholar
  37. 37.
    Stroup, M. & Mccreary, J. (1975): Cr” another high frequency blood group factor. (Abstract). Transfusion 15, 522.Google Scholar
  38. 38.
    Täte, G., Uchikawa, M., Tanner, M. J. A., Judson, P. A., Parsons, S. F., Mallinson, G. & Anstee, D. J. (1989): Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype. Biochem. J. 261, 489–493.PubMedGoogle Scholar
  39. 39.
    Telen, M. J., Hall, S. E., Green, A. M., Moulds, J. J. & Rosse, W. F. (1988): Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J. Exp. Med. 167, 1993–1998.PubMedCrossRefGoogle Scholar
  40. 40.
    Telen, M. J., Rao, N. & Lublin, D. M. (1995): Location of WES” on decay-accelerating factor. Transfusion 35, 278.PubMedCrossRefGoogle Scholar
  41. 41.
    Telen, M. J., Rao, N., Udani, M., Thompson, E. S., Kaufman, R. M. & Lublin, D. M. (1994): Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 84, 3205–3211.PubMedGoogle Scholar
  42. 42.
    Tregellas, W. M. (1984): Description of a new blood group antigen, Esa. 18th Congress of the International Society of Blood Transfusion, Karger, Basel, Abstracts p. 163.Google Scholar
  43. 43.
    Walthers, L., Salem, M., Tessel, J., Laird-Fryer, B. & Moulds, J. J. (1983): The Inab phenotype: another example found. (Abstract). Transfusion 23, 423.Google Scholar
  44. 44.
    Wang, L., Uchikawa, M., Tsuneyama, H., Tokunaga, K., Tadokoro, K. & Juji, T. (1998): Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype. Blood 91, 680–684.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • Helmut Schenkel-Brunner
    • 1
  1. 1.Institut für Medizinische BiochemieUniversität WienViennaAustria

Personalised recommendations